Steroid-resistant Vogt-Koyanagi-Harada-like uveitis due to BRAF/MEK inhibitor, successfully treated with adalimumab

Eur J Dermatol. 2024 Aug 1;34(4):442-444. doi: 10.1684/ejd.2024.4730.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab* / adverse effects
  • Adalimumab* / therapeutic use
  • Anti-Inflammatory Agents / adverse effects
  • Anti-Inflammatory Agents / therapeutic use
  • Drug Resistance
  • Female
  • Humans
  • Male
  • Middle Aged
  • Protein Kinase Inhibitors / adverse effects
  • Protein Kinase Inhibitors / therapeutic use
  • Proto-Oncogene Proteins B-raf* / antagonists & inhibitors
  • Proto-Oncogene Proteins B-raf* / genetics
  • Sulfonamides / adverse effects
  • Sulfonamides / therapeutic use
  • Uveomeningoencephalitic Syndrome* / drug therapy

Substances

  • Adalimumab
  • Proto-Oncogene Proteins B-raf
  • Protein Kinase Inhibitors
  • BRAF protein, human
  • Anti-Inflammatory Agents
  • Sulfonamides